Giant Papillary Conjunctivitis Market is segmented By Treatment (Medications, Surgical Interventions), By Route of Administration (Topical, Oral), By ....
Market Size in USD
CAGR7.5%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 7.5% |
Market Concentration | Medium |
Major Players | Allergan plc, Alcon Laboratories, Inc., Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, CooperVision, Inc., Allergan plc |
The giant papillary conjunctivitis market is estimated to be valued at USD 1.2 Bn in 2024 and is expected to reach USD 1.99 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. The market is expected to witness positive growth over the forecast period due to rising incidences of digital eye strain due to extensive use of digital devices. Additionally, increasing awareness about various eye diseases and their treatment options among consumers is further expected to support the market growth.